Company Filing History:
1 out of 21 
1 out of 2 
1 out of 39 Years Active: 2001-2003
Title: The Innovations of Keith Schappert
Introduction
Keith Schappert is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of genetics and neurology, holding a total of 4 patents. His work focuses on methods for diagnosing and treating neurological diseases, particularly Alzheimer's disease.
Latest Patents
One of his latest patents involves the genotyping of the paraoxonase 1 gene for prognosing, diagnosing, and treating Alzheimer's disease. This invention provides methods for identifying or stratifying subjects who have Alzheimer's disease or are at risk for it by determining the genotype at nucleotide 172 of the PON1 allele of the subject. Another significant patent addresses methods for treating or identifying a subject at risk for a neurological disease by determining the presence of a variant GPIIIa and/or variant BPIIb allele. This invention offers methods for treating or identifying subjects who have a neurological disease or are at risk for one by determining the presence of these specific alleles.
Career Highlights
Throughout his career, Keith Schappert has worked with various companies, including Variagenics, Inc. His innovative approaches have contributed to advancements in medical diagnostics and treatment options.
Collaborations
Keith has collaborated with notable professionals in his field, including Pierre Sévigny and Heiko Wiebusch. Their combined expertise has furthered the impact of his inventions.
Conclusion
Keith Schappert's contributions to the field of genetics and neurology through his patents demonstrate his commitment to advancing medical science. His work continues to influence the diagnosis and treatment of neurological diseases.